Revolution Medicines Inc (RVMD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $36.09B
Last updated: Nov 17, 2026 at 4:43 PM ET
Revolution Medicines Inc (RVMD) Stock Chart
Revolution Medicines (RVMD) has a latest price of $162.69 on Nov 17, 2026, 27.5% below its 52-week high of $224.31. Its price rose 140.1% over the past 12 months. The month-end price rose 550.1% over the 5 years through Oct 2026, a compound annual rate of 45.4%.
Price Chart
From Feb 2020 to Oct 2026, its highest month-end close was $205.57 in Aug 2026 and its lowest $16.98 in May 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RVMD with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RVMD.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 24.2%, and over 6 months it rose 10.4%. The month-end price rose 866.2% over the 3 years through Oct 2026, a compound annual rate of 113.0%.
| Period | Change |
|---|---|
| 1 month | -10.7% |
| 3 months | -24.2% |
| 6 months | +10.4% |
| 12 months | +140.1% |
| 12 months, with dividends | +140.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +866.2% | +113.0% |
| 5 years | +550.1% | +45.4% |
Price by Year
Its best calendar year was 2025, when the price rose 82.1%, and its weakest was 2021, when it fell 36.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $191.31 | +140.2% |
| 2025 | $79.65 | +82.1% |
| 2024 | $43.74 | +52.5% |
| 2023 | $28.68 | +20.4% |
| 2022 | $23.82 | -5.4% |
| 2021 | $25.17 | -36.4% |
Trading Range
The price is 15.6% below its 50-day average of $192.71 and 1.3% above its 200-day average of $160.55.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $162.69 | |
| 52-week high | $224.31 | -27.5% |
| 52-week low | $69.50 | +134.1% |
| 50-day average | $192.71 | -15.6% |
| 200-day average | $160.55 | +1.3% |
Price Risk
Over 3 years, its largest fall from a peak was 48.6%.
| Measure | Value |
|---|---|
| 1-year beta | 1.31 |
| Largest fall, 1 year | -26.4% |
| Largest fall, 3 years | -48.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RVMD
What is RVMD's 1-year price change?
Revolution Medicines's price rose 140.1% over the past 12 months. With dividends included, the 12-month total return was 140.1%.
What is RVMD's 5-year price change?
Revolution Medicines's month-end price rose 550.1% over the 5 years through Oct 2026, a compound annual rate of 45.4%. These figures leave out dividends.
What is RVMD's 52-week high and low?
Revolution Medicines's 52-week high is $224.31 and its 52-week low is $69.50. Its latest price of $162.69 on Nov 17, 2026 is 27.5% below the high.
What is RVMD's beta?
Revolution Medicines's 1-year beta against the S&P 500 is 1.31, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 26.4%.
Is the RVMD chart free?
Yes. Advanced Charting for RVMD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RVMD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors